Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-10-07
1997-07-29
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, A61K 3830
Patent
active
056522142
ABSTRACT:
A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method including the step of administering to the mammal one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
REFERENCES:
patent: 4511390 (1985-04-01), Kauer
patent: 4699875 (1987-10-01), Appel
patent: 4783524 (1988-11-01), Larsen et al.
patent: 4801575 (1989-01-01), Pardridge
patent: 5068224 (1991-11-01), Fryklund et al.
patent: 5093317 (1992-03-01), Lewis et al.
Baxter, Comp. Biochem. Physiol. 91B:229-235, 1988.
Daughaday et al., Endocrine Rev. 10:68-91, 1989.
D'Ercole, J. Devel. Physiol. 9:481-495, 1987.
Hintz et al., Horm. Metab. Res. 20:344-347, 1988.
Baskin et al., TINS 11:107-111, 1988.
Sara et al., Proc. Natl. Acad. Sci. USA 83:4904-4907, 1986.
Francis et al., Biochem. J. 251:95-103, 1988.
Sara et al., Neurosci. Let. 34:39-44, 1982.
Aizenman et al., Brain Res. 406:32-42, 1987.
Fellows et al., Soc. Neurosci. 13:1615, Abstract 445.14, 1987.
Onifer et al., Soc. Neurosci. 13:1615, Abstract 445.13, 1987.
Bothwell, J. Neurosci. Res. 8:225-231, 1982.
Recio-Pinto et al., J. Neurosci. 6:1211-1219, 1986.
Recio-Pinto et al., J. Neurosci. Res. 19:312-320, 1988.
Mattsson et al., J. Cell Biol. 102:1949-54, 1986.
Sara et al., J. Dev. Physiol. 1:343-350, 1979.
Sara et al., Prog. Brain Res. 73:87-99, 1988.
Sara et al., Neurobiol. Aging 3:117-120, 1982.
Nilsson et al., Neurosci. Let. 88:221-226, 1988.
Hansson et al., Acta. Physiol. Scand. 132;35-41, 1988.
Sjoberg et al., Brain Res. 485:102-108, 1989.
Coy et al., Biochem. Biophys. Res. Commun. 73:632-8, 1976.
Pardridge, Endocrine Reviews 7:314-330, 1986.
Blundell et al., Fed. Proc. 42:2592-2597, 1983.
Kastin et al., Pharmac. Biochem. Behav. 11:713-716, 1979.
Rapoport et al., Science 207:84-86, 1980.
Pardridge et al., Biochem. Biophys. Res. Commun. 146:307-313, 1987.
Riekkinen et al., Peptides 8:261-265, 1987.
Creveling et al., Experienta 25:26-27, 1969.
Bodor et al., Science 214:1370-1372, 1981.
Francis et al., Art to Science in Tissue Culture, HyClone Laboratories, Inc., vol. 11, pp. 3, 5, 6, and 7, Winter 1992.
McManaman et al., Dev. Biol. 112:248-252, 1985.
Schwartz et al., Dev. Brain Res. 1:403-413, 1981.
Kanje et al., Brain Res. 381:24-28, 1986.
Hansson et al., Acta. Physiol. Scand. 126:609-614, 1986.
Sara et al., Biol. Psychiat. 18:803-811, 1983.
MacDonnell et al., Proc. Natl. Acad. Sci. USA 74:4681-4684, 1977.
Schwartz et al., Archives of Biochemistry & Biophysics 181:542-549, 1977.
Hintz et al., J. Clinical Endocrinology and Metabolism 54:442-446, 19822.
Russell et al., Life Sciences 19:1297-1306, 1976.
Rinehart et al., Proc. Natl. Acad. Sci. USA 82:4365-4368, 1985.
Hartikka et al., The Journal of Neuroscience 8:2967-2985, 1988.
Hayashi et al., Developmental Brain Research 36:109-120, 1987.
Knusel et al., The Journal of Neuroscience 10:558-570, 1990.
Recio-Pinto et al., Proc. Natl. Acad. Sci. 81:2562-2566, 1984.
Williams et al., Proc. Natl. Acad. Sci. 83:9231-9235, 1986.
Taylor et al., Drug Development Research 11:75-86, 1987.
DiCicco-Bloom et al., Proc. Natl. Acad. Sci. 85:4066-4070, 1988.
McManaman et al., Neuron 4:891-898, 1990.
Oppenheim et al., Science 251:1616-1617, 1991.
Hayward et al. in Peptides 1974--Proceedings of the Thirteenth European Peptide Symposium. Wolman, Editor. John Wiley & Sons (New York), 1974, pp. 287-295.
Goodman et al., Accounts of Chemical Research 12:1-7, 1979.
The Merck Manual of Diagnosis & Therapy, 11th ed., pp. 1161-1163, (1966).
Baldino Frank
Callison Kathleen V.
Iqbal Mohamed
Kauer James C.
Lewis Michael E.
Burgoon, Jr. Richard P.
Carroll Kathleen
Cephalon Inc.
Russel Jeffrey E.
Sausen George N.
LandOfFree
Treating disorders by application of insulin-like growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating disorders by application of insulin-like growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating disorders by application of insulin-like growth factors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-633732